Imperial College Healthcare NHS TrustLondon, United Kingdom
Disclosure information not submitted.
MON-022 - Osilodrostat Therapy and 11C-Methionine PET to Improve Corticotroph Pituitary Adenoma Detection and Localisation in Patients with Cushing Disease (OPTIMAL); Study Design and Rationale
Monday, June 15, 20269:00 AM - 2:00 PM CT
MON-023 - Venous Thromboembolism Prophylaxis with Rivaroxaban in ACTH-Dependent Cushing Syndrome: A Single-Centre Retrospective Cohort Study
.jpg)
.jpg)